Maruti Suzuki, Lupin, SpiceJet in Focus Today

31 Dec 2014, 03:21 PM IST

Maruti Suzuki/Hero MotoCorp/M&M: As per reports excise duty benefit of 3-6 per cent that was given to auto companies in March this year is unlikely to be extended to the new year. It is very likely that if the excise duty is hiked on passenger vehicles and two-wheelers, then auto companies will pass on the burden to the end consumer by hiking price.
JSW Holdings, the investment arm of JSW Group, has sought shareholder's nod to give guarantee, mortgage or pledge, among others on properties of the company.
Mangalore Chemicals & Fertilizers (MCFL): Zuari Group plans to spend Rs 398.2 crore to buy up to 36.56 per cent stake in MCFL, which turns out to Rs 91.9 per share. At present group has 16.47 per cent stake in MCFL.
Lupin has received a tentative approval from US Food and Drug Administration (FDA) for its drug Darunavir Ethanolate, which is a generic version of Prezista tablets used in treating HIV infection to sell in American market.
SpiceJet has extended its flight cancellations till January 31, 2015. The cancellation is affecting over 300 flights.
Wockhardt/ Cadila Healthcare: These two companies have recalled certain lots of hypertension drug as it 'failed dissolution specification', as per the US FDA.
Atul Auto: Goldman Sachs Asset Management has bought 4.05 lakh shares in the company at an average price of Rs 616.4 apiece on BSE on Tuesday.